Willow Biosciences Inc.

Willow is a publicly traded biotechnology company focused on revolutionizing industrial manufacturing of core ingredients that have traditionally been derived from plants.

Our first ingredients to market are cannabinoids – we are commercial on CBG, with a robust pipeline behind us.

We do in 10 days what typically takes the plant four to six months to do, at >99% purity and at a fraction of the cost and energy.